{"id":41788,"date":"2025-09-18T14:44:46","date_gmt":"2025-09-18T06:44:46","guid":{"rendered":"https:\/\/flcube.com\/?p=41788"},"modified":"2025-09-18T14:44:46","modified_gmt":"2025-09-18T06:44:46","slug":"eli-lillys-mounjaro-shows-promising-results-in-children-with-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41788","title":{"rendered":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes"},"content":{"rendered":"\n<p>A recent clinical study published by <strong>Eli\u202fLilly &amp; Co.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/LLY:NYSE\">NYSE: LLY<\/a>) demonstrates that the GLP\u20111 agonist <strong>Mounjaro (tirzepatide)<\/strong> can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly <strong>100 pediatric patients<\/strong> (ages\u202f10\u201117), reported an average <strong>2\u202f% reduction in HbA1c<\/strong> and a <strong>10\u202f% decline in body weight<\/strong> after one year of therapy.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-study-highlights\">Study Highlights<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Blood\u2011glucose control<\/strong>: Average HbA1c fell by ~2\u202f%.<\/li>\n\n\n\n<li><strong>Weight loss<\/strong>: Participants lost >\u202f10\u202f% of baseline body weight.<\/li>\n\n\n\n<li><strong>Safety profile<\/strong>: No new safety signals; tolerability comparable to adults.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-regulatory-strategy\">Regulatory Strategy<\/h4>\n\n\n\n<p>Eli\u202fLilly has submitted the data to <strong>global drug regulators<\/strong> with the goal of expanding Mounjaro\u2019s label to <strong>pediatric type\u202f2 diabetes<\/strong>. Approval would mark the first GLP\u20111 product specifically cleared for children with this condition\u2014a growing public\u2011health concern linked to rising obesity rates.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-competitive-landscape\">Competitive Landscape<\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Novo\u202fNordisk<\/strong> is also testing its GLP\u20111 agents (Wegovy, Saxenda, Ozempic) in children as young as 6.<\/li>\n\n\n\n<li><strong>Wegovy &amp; Saxenda<\/strong> are currently approved for obesity in patients \u2265\u202f12\u202fyears in the U.S. and EU.<\/li>\n\n\n\n<li><strong>Ozempic<\/strong> remains unapproved for pediatric use, leaving a regulatory gap that Mounjaro could fill.<\/li>\n<\/ul>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-market-implications\">Market Implications<\/h4>\n\n\n\n<p>If cleared, Mounjaro would broaden Eli\u202fLilly\u2019s portfolio into a niche market projected to reach <strong>$4\u202fbillion<\/strong> by 2030, driven by the increasing prevalence of childhood obesity and type\u202f2 diabetes. The drug\u2019s dual action\u2014glucose lowering and weight reduction\u2014aligns with clinicians\u2019 call for more aggressive early interventions.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A recent clinical study published by Eli\u202fLilly &amp; Co. (NYSE: LLY) demonstrates that the GLP\u20111&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41789,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[39,911],"class_list":["post-41788","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","tag-diabetes","tag-nyse-lly"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"A recent clinical study published by Eli\u202fLilly &amp; Co. (NYSE: LLY) demonstrates that the GLP\u20111 agonist Mounjaro (tirzepatide) can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly 100 pediatric patients (ages\u202f10\u201117), reported an average 2\u202f% reduction in HbA1c and a 10\u202f% decline in body weight after one year of therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41788\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes\" \/>\n<meta property=\"og:description\" content=\"A recent clinical study published by Eli\u202fLilly &amp; Co. (NYSE: LLY) demonstrates that the GLP\u20111 agonist Mounjaro (tirzepatide) can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly 100 pediatric patients (ages\u202f10\u201117), reported an average 2\u202f% reduction in HbA1c and a 10\u202f% decline in body weight after one year of therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41788\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-18T06:44:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes\",\"datePublished\":\"2025-09-18T06:44:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788\"},\"wordCount\":249,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1804.webp\",\"keywords\":[\"Diabetes\",\"NYSE: LLY\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41788#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41788\",\"name\":\"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1804.webp\",\"datePublished\":\"2025-09-18T06:44:46+00:00\",\"description\":\"A recent clinical study published by Eli\u202fLilly & Co. (NYSE: LLY) demonstrates that the GLP\u20111 agonist Mounjaro (tirzepatide) can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly 100 pediatric patients (ages\u202f10\u201117), reported an average 2\u202f% reduction in HbA1c and a 10\u202f% decline in body weight after one year of therapy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41788\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1804.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1804.webp\",\"width\":1080,\"height\":608,\"caption\":\"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41788#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes - Insight, China&#039;s Pharmaceutical Industry","description":"A recent clinical study published by Eli\u202fLilly & Co. (NYSE: LLY) demonstrates that the GLP\u20111 agonist Mounjaro (tirzepatide) can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly 100 pediatric patients (ages\u202f10\u201117), reported an average 2\u202f% reduction in HbA1c and a 10\u202f% decline in body weight after one year of therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41788","og_locale":"en_US","og_type":"article","og_title":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes","og_description":"A recent clinical study published by Eli\u202fLilly & Co. (NYSE: LLY) demonstrates that the GLP\u20111 agonist Mounjaro (tirzepatide) can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly 100 pediatric patients (ages\u202f10\u201117), reported an average 2\u202f% reduction in HbA1c and a 10\u202f% decline in body weight after one year of therapy.","og_url":"https:\/\/flcube.com\/?p=41788","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-18T06:44:46+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41788#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41788"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes","datePublished":"2025-09-18T06:44:46+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41788"},"wordCount":249,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41788#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp","keywords":["Diabetes","NYSE: LLY"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41788#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41788","url":"https:\/\/flcube.com\/?p=41788","name":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41788#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41788#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp","datePublished":"2025-09-18T06:44:46+00:00","description":"A recent clinical study published by Eli\u202fLilly & Co. (NYSE: LLY) demonstrates that the GLP\u20111 agonist Mounjaro (tirzepatide) can help children as young as 10 manage blood sugar and achieve significant weight loss. The trial, involving roughly 100 pediatric patients (ages\u202f10\u201117), reported an average 2\u202f% reduction in HbA1c and a 10\u202f% decline in body weight after one year of therapy.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41788#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41788"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41788#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp","width":1080,"height":608,"caption":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41788#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eli\u202fLilly\u2019s Mounjaro Shows Promising Results in Children with Type\u202f2 Diabetes"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1804.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41788"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41788\/revisions"}],"predecessor-version":[{"id":41790,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41788\/revisions\/41790"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41789"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}